Physician profile
Maxim Sulla
NPI 1720007776
$895.56
in general payments reported to CMS, 2019-2025
12 companies · $14.34 in 2025
The $14.34 reported for 2025 was less than what a typical Pediatric Dentistry provider received nationally (typical 2025 total: $42.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $60.00 · 2021: $423 · 2022: $29.99 · 2023: $186 · 2024: $54.41 · 2025: $14.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $407.50 | 2021-2022 | |
| Henry Schein, INC. | $91.99 | 2019 | |
| Nobel Biocare USA | $70.79 | 2023 | Nobelactive |
| Hu-Friedy Mfg. Co., LLC | $60.00 | 2020 | |
| Align Technology, INC. | $54.41 | 2024 | Invisalign |
| Nusmile, LTD. | $52.21 | 2023 | Bioflx |
| Kerr Corporation | $49.94 | 2023 | Optibond Xtr |
| Dentsply Sirona INC | $33.13 | 2021-2025 | Midwest Stylus Plus |
| Philips North America LLC | $29.41 | 2019-2023 | |
| Ultradent Products INC | $19.00 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $14.69 | 2021 | |
| Centrix INC | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxim Sulla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.